Literature DB >> 23594095

Anionic polymer-coated lipoplex for safe gene delivery into tumor by systemic injection.

Yoshiyuki Hattori1, Haruka Yamasaku, Yoshie Maitani.   

Abstract

In this study, we developed an anionic lipoplex by coating cationic lipoplex with anionic polymers such as hyaluronan (HA), chondroitin sulfate C (CS) and poly-l-glutamic acid (PLE) to deliver the plasmid DNA efficiently into the tumor by avoiding interaction with erythrocytes. The sizes of HA-, CS- and PLE-coated lipoplexes were ∼200 nm and the ζ-potentials were negative. CS- and PLE-coated lipoplexes did not induce agglutination after mixing with erythrocytes, but cationic and HA-coated lipoplexes exhibited agglutination. In terms of biodistribution and gene expression after intravenous administration, cationic and HA-coated lipoplexes largely accumulated and induced gene expression in the lung. In contrast, CS- and PLE-coated lipoplexes did not exhibit high gene expression in the lung and mainly accumulated in the liver. However, in tumor, differences in lipoplex accumulation and gene expression were not observed among the lipoplexes. In terms of toxicity after intravenous injection, CS- and PLE-coated lipoplexes did not increase tumor necrosis factor-α, aspartate aminotransferase and alanine aminotransferase concentrations in blood. From these findings, CS and PLE coatings for cationic lipoplex might produce safe systemic vectors, although they did not increase gene expression in tumor.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23594095     DOI: 10.3109/1061186X.2013.789035

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  8 in total

1.  Spatial Control of Gene Expression by Nanocarriers Using Heparin Masking and Ultrasound-Targeted Microbubble Destruction.

Authors:  Beata Chertok; Robert Langer; Daniel G Anderson
Journal:  ACS Nano       Date:  2016-07-29       Impact factor: 15.881

2.  Nanoparticle-based targeted gene therapy for lung cancer.

Authors:  Hung-Yen Lee; Kamal A Mohammed; Najmunnisa Nasreen
Journal:  Am J Cancer Res       Date:  2016-05-01       Impact factor: 6.166

3.  Gene delivery to Her-2+ breast cancer cells using a two-component delivery system to achieve specificity.

Authors:  Max Kullberg; Ryan McCarthy; Thomas J Anchordoquy
Journal:  Nanomedicine       Date:  2014-03-12       Impact factor: 5.307

4.  In vivo siRNA delivery system for targeting to the liver by poly-l-glutamic acid-coated lipoplex.

Authors:  Yoshiyuki Hattori; Ayako Nakamura; Shohei Arai; Mayu Nishigaki; Hiroyuki Ohkura; Kumi Kawano; Yoshie Maitani; Etsuo Yonemochi
Journal:  Results Pharma Sci       Date:  2014-01-25

5.  Poly(γ-glutamic acid)-coated lipoplexes loaded with Doxorubicin for enhancing the antitumor activity against liver tumors.

Authors:  Na Qi; Bo Tang; Guang Liu; Xingsi Liang
Journal:  Nanoscale Res Lett       Date:  2017-05-19       Impact factor: 4.703

6.  Tumor Microenvironment Targeted Nanotherapy.

Authors:  Clara Fernandes; Divya Suares; Mayur C Yergeri
Journal:  Front Pharmacol       Date:  2018-10-31       Impact factor: 5.810

7.  Gene delivery into hepatic cells with ternary complexes of plasmid DNA, cationic liposomes and apolipoprotein E-derived peptide.

Authors:  Yoshiyuki Hattori; Yuta Nakagawa; Hiraku Onishi
Journal:  Exp Ther Med       Date:  2019-08-07       Impact factor: 2.447

8.  Effects of PEG anchors in PEGylated siRNA lipoplexes on in vitro gene‑silencing effects and siRNA biodistribution in mice.

Authors:  Yoshiyuki Hattori; Kyoko Tamaki; Sho Sakasai; Kei-Ichi Ozaki; Hiraku Onishi
Journal:  Mol Med Rep       Date:  2020-09-18       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.